Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham

Birmingham, Alabama 35294

0 studies enrolling now · 38 studies all time

What they study most

Bladder Cancer, Brain Tumor, Brain Tumors, Brain and Central Nervous System Tumors, Breast Cancer, Central Nervous System Tumor, Central Nervous System Tumors, Cervical Cancer, Childhood Germ Cell Tumor, Fallopian Tube Cancer, Gestational Trophoblastic Tumor, Glioblastoma Multiforme

Studies at this site

• Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid Tumors — Completed
• Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia — Completed
• Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer — Completed
• Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis — Completed
• High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma — Completed
• Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma — Completed
• Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation — Completed
• Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic Lymphoma — Completed
• Radiation Therapy and Temozolomide Followed by Temozolomide and Poly ICLC in Treating Patients With Newly Diagnosed GBM — Completed
• Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer — Completed
• Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer — Completed
• Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer — Completed
• Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary Central Nervous System (CNS) Germ Cell Tumor — Completed
• Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas — Completed
• Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Low-Risk Gestational Trophoblastic Tumor After a Molar Pregnancy — Stopped early
• Captopril in Treating Patients With Non-Small Cell Lung Cancer or Limited-Stage Small Cell Lung Cancer That Has Been Previously Treated With Radiation Therapy With or Without Chemotherapy — Stopped early
• Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors — Completed
• Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer — Completed
• Cetuximab + / - Carboplatin for Estrogen Receptor-Negative, Progesterone Receptor-Negative Metastatic Breast Cancer — Completed
• Lestaurtinib, Cytarabine, and Idarubicin in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia — Completed
• Brain Irradiation in Treating Patients With Limited-Stage Small Cell Lung Cancer — Completed
• Iodine I 131 Monoclonal Antibody TNT-1/B in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme — Completed
• Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma — Completed
• S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma — Completed
• hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma — Completed
• Cytarabine in Treating Young Patients With Recurrent or Refractory Ewing's Sarcoma — Completed
• Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma — Completed
• Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma — Completed
• Vinblastine and Carboplatin in Treating Young Patients With Newly Diagnosed or Recurrent Low-Grade Glioma — Completed
• Radiolabeled Monoclonal Antibody in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma — Stopped early
• Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma — Stopped early
• Rituximab in Treating Patients With Refractory or Relapsed Primary CNS Lymphoma — Stopped early
• Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma — Completed
• Forodesine (BCX-1777) in Treating Patients With Refractory Stage IIA, Stage IIB, Stage III, Stage IVA, or Stage IVB Cutaneous T-Cell Lymphoma — Completed
• Radiation Therapy, Chemotherapy, and Bevacizumab in Treating Patients With Recurrent, Unresectable or Stage III or Stage IV Non-Small Cell Lung Cancer — Stopped early
• Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme — Completed
• Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung Cancer — Status unconfirmed
• Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass — Status unconfirmed